Treatment of chronic perennial allergic rhinitis: a double-blind trial of cromolyn sodium
- PMID: 409315
Treatment of chronic perennial allergic rhinitis: a double-blind trial of cromolyn sodium
Abstract
In a double-blind, crossover study to determine the efficacy of cromolyn sodium in chronic perennial allergic rhinitis five of 12 patients with significant sneezing problems and four of 12 patients with significant rhinorrhea showed major improvement after a four-week course of the drug. Nasal eosinophils disappeared in five of six patients after a course of cromolyn sodium.
Similar articles
-
Rynacrom (sodium cromoglycate) in intractable perennial rhinitis.N Z Med J. 1975 Oct 22;82(550):265-6. N Z Med J. 1975. PMID: 813161 Clinical Trial.
-
Treatment of perennial rhinitis with 2% solution of sodium cromoglycate.Rhinology. 1975 Aug;13(2):91-7. Rhinology. 1975. PMID: 817384 Clinical Trial.
-
Efficacy double-blind, crossover study of sodium cromoglycate in patients with seasonal allergic rhinitis.Ann Allergy. 1977 Jan;38(1):42-45. Ann Allergy. 1977. PMID: 402093 Clinical Trial.
-
The effect of cromolyn on nasal disease.Ear Nose Throat J. 1986 Oct;65(10):449-56. Ear Nose Throat J. 1986. PMID: 3096687 Review. No abstract available.
-
Use of intranasal cromolyn sodium for allergic rhinitis.Mayo Clin Proc. 2002 Apr;77(4):350-4. doi: 10.4065/77.4.350. Mayo Clin Proc. 2002. PMID: 11936930 Review.
Cited by
-
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073. Int Forum Allergy Rhinol. 2018. PMID: 29438602 Free PMC article.